Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.59% | 21.12% | 28.71% | 16.01% | 19.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.59% | 21.12% | 28.71% | 16.01% | 19.48% |
| Cost of Revenue | 39.13% | 25.98% | 39.44% | 18.69% | 16.41% |
| Gross Profit | 11.87% | 19.32% | 25.51% | 15.40% | 20.14% |
| SG&A Expenses | 3.63% | 53.62% | 5.69% | 14.83% | 17.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.61% | 41.01% | 39.93% | 0.56% | 25.25% |
| Operating Income | -33.70% | -30.81% | 6.12% | 125.60% | 8.09% |
| Income Before Tax | -30.59% | -27.42% | 8.56% | 128.81% | 10.41% |
| Income Tax Expenses | -38.03% | 173.56% | 3.41% | -2.40% | -13.63% |
| Earnings from Continuing Operations | -28.69% | -54.55% | 10.35% | 243.16% | 18.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.69% | -54.55% | 10.35% | 243.16% | 18.85% |
| EBIT | -33.70% | -30.81% | 6.12% | 125.60% | 8.09% |
| EBITDA | -30.47% | -25.46% | 5.58% | 97.56% | 6.97% |
| EPS Basic | -29.32% | -54.98% | 9.04% | 239.10% | 17.74% |
| Normalized Basic EPS | -31.21% | -28.10% | 7.27% | 126.14% | 9.38% |
| EPS Diluted | -29.49% | -55.05% | 10.13% | 240.00% | 16.42% |
| Normalized Diluted EPS | -30.89% | -28.01% | 7.43% | 125.38% | 8.67% |
| Average Basic Shares Outstanding | 0.89% | 0.94% | 1.20% | 1.17% | 0.95% |
| Average Diluted Shares Outstanding | 0.43% | 0.82% | 1.06% | 1.54% | 1.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |